OTC:SMNR | Profit Breakdown | Semnur Pharmaceuticals, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2022-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$4.22M-$4.35M
2026-03-31-$4.58M-$4.58M
2025-12-31-$6.16M-$6.16M
2025-09-30-$152.59M-$152.59M
2025-06-30-$999,000.00-$999,000.00
2025-03-31-$665,000.00-$665,000.00
2024-12-31-$776,000.00-$776,000.00
2024-09-30-$1.3M-$1.3M
2024-06-30-$168,186.00-$1.11M
2024-03-31-$368,252.00-$1.51M
2023-12-31-$182,482.00$553,343.00
2023-09-30-$505,895.00$630,586.00
2023-06-30-$563,701.00$457,709.00
2023-03-31-$1.01M
2022-12-31-$684,668.00
2022-09-30$307,468.00
2022-06-30-$30,847.00
2022-03-31-$11,343.00

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$160.42M$0.00-$160.42M
2024-12-31-$4.69M$0.00-$4.69M
2023-12-31-$3.17M$632,536.00
2022-12-31-$419,390.00

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.